Camber Launches Indomethacin Suppositories
Camber Pharmaceuticals recently added Indomethacin Suppositories [IN-doe-METH-a-sin] to its portfolio.
Indomethacin Suppositories are a nonsteroidal anti-inflammatory drug indicated for:
- Moderate to severe rheumatoid arthritis including acute flares of chronic disease
- Moderate to severe ankylosing spondylitis
- Moderate to severe osteoarthritis
- Acute painful shoulder (bursitis and/or tendinitis)
- Acute gouty arthritis
Camber’s Indomethacin Suppositories are available in 50mg strength, supplied as 30 suppositories per package.
Click here to learn more about this product.
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






